期刊文献+

不同血糖水平的2型糖尿病患者的人体测量指标和血脂比较研究 被引量:7

The comparisons of body composition and blood lipid profiles among diabetic outpatients with different HbA1c levels
暂未订购
导出
摘要 目的对不同血糖控制水平的2型糖尿病患者的人体测量及血脂生化指标进行比较分析。方法选择2型糖尿病患者179例,取空腹血测定血糖、糖化血红蛋白(HbA1c)、糖化血清蛋白、三酰甘油(TG)、总胆固醇(TC)、高密度及低密度脂蛋白胆固醇(HDL-C、LDL-C)等指标,并进行身高、体质量、腰围、臀围、瘦体质量、体脂肪含量等人体测量,计算体质量指数(BMI)、腰臀比、腰围身高比、体脂肪百分比,按HbA1c<6.5%和HbA1c≥6.5%将研究对象分为HbA1c控制组和HbA1c控制不良组,比较两组人群上述人体测量及血脂生化指标的差异。结果HbA1c控制不良组人群的BMI、臀围、腰围身高比、体脂肪含量及百分比显著大于HbA1c控制组(P<0.05),TC、LDL-C亦显著高于HbA1c控制组(P<0.05)。结论2型糖尿病患者的血糖控制水平与BMI、体脂及血脂密切相关,在代谢控制中应兼顾。 Objective To compare the characteristics of body composition and lipid metabolism among diabetic outpatients with different HbA1c levels.Methods 179 subjects with type 2 diabetes mellitus(T2DM) were divided into two groups according to HbA1c levels of 6.5%.The anthropometric measurements of body height,weight,body mass index(BMI),waist circumference(WC),hip circumference(HC),body fat weight and percentage,blood triglyceride(TG),total cholesterol(TC),high-density and low-density lipoprotein cholesterol(HDL-C,LDL-C) were measured and compared between the two groups.Results In the group with HbA1c≥6.5%,parameters of body composition such as BMI,HC,ratio of WC/body height,body fat weight and percentage were significantly higher than those in the group with HbA1c 〈6.5%(P〈0.05),meanwhile blood TC and LDL-C were also significantly higher(P〈0.05).Conclusion Higher level of HbA1c in T2DM patients is concomitant with poor control of BMI,body fat and blood lipid profiles.These should be concerned simultaneously in order to achieve a good glycemic control.
出处 《中国临床保健杂志》 CAS 2009年第6期569-571,共3页 Chinese Journal of Clinical Healthcare
关键词 糖尿病 2型 血糖 血红蛋白A 糖基化 体脂肪率 高脂血症 Diabetes mellitus type 2 Blood glucose Hemoglobin A glycosylated Adiposity Hyperlipidemias
  • 相关文献

参考文献7

二级参考文献24

共引文献3418

同被引文献64

  • 1张磊,董砚虎.肥胖体表测量指标与糖尿病及心血管疾病的研究进展[J].国外医学(内分泌学分册),2005,25(4):257-258. 被引量:23
  • 2葛声,蔡东联,唐彦,桂腊梅,曹芸.采用主成分分析法对糖尿病住院患者营养状况综合评价[J].中国临床营养杂志,2005,13(5):285-288. 被引量:11
  • 3张震巍,陈洁,唐智柳,胡仁明,鹿斌.中国糖尿病直接卫生费用研究[J].中国卫生资源,2007,10(3):162-163. 被引量:27
  • 4De Galan BE,Perkovic V,Ninomiya T,et al.Lowering blood pressure reduces renal events in type 2 diabetes[J].J Am Soc Nephrol,2009,20(4):883-892.
  • 5Mourad JJ,Le Jeune S.Blood pressure control,risk factors and cardiovascular prognosis in patients with diabetes:30 years of progress[J].J Hypertens Supp,2008,26(3):S7-13.
  • 6ADVANCE Collaborative Group,Patel A,MacMahon S,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2560-2572.
  • 7Beulens JW,Patel A,Vingerling JR,et al.Effects of blood pressure lo domised controlled trial[J].Diabetologia,2009,52(10):2027- 2036.
  • 8Collins R,Armitage J,Parish S,et al.MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes:a randomised placebo-controlled trial[J].Lancet,2003,361 (9374):2005- 2016.
  • 9Colhon HM,Betteridge DJ,Durrington PN,et al.Primary prevention of cardiovascular disease with atorvastain in type 2 diabetes in the Collaborstive AtoRvastatin Diabetes Study(CARDS):a multicentre randomized placebo-controlled trail[J].Lancet,2004,110:227-239.
  • 10Keech A,Simes RJ,Barter P,et al.Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):randomised controlled trial[J].Lancet,2005,366(9500):1849 - 2361.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部